Hocco has raised $10 million in its Series B funding round; 1-India Family Mart has raised $12 million in Series D funding; and MedVital has secured pre-seed funding.
Chona Family Office, Sauce VC lead funding in Hocco
Gujarat-based premium ice cream brand Hocco has raised $10 million in its Series B funding round co-led by the Chona Family Office and Sauce VC.
The funding, which is part of a larger $20-million round, will be used to expand manufacturing capacity, enter new markets across India, and strengthen Hocco’s supply-chain and distribution networks. The company also plans to invest in product development and brand marketing.
Hocco has positioned itself as a premium ice cream brand, offering both regional and globally-inspired flavours. It has expanded its presence in several Indian cities since its founding and is aiming to scale further amid growing demand for premium food products.
1-India Family Mart raises $12m
Value retail chain 1-India Family Mart has raised $12 million in its Series D funding round, from a mix of existing and new investors.
The round saw participation from Gulf Islamic Investments, Singapore-based Foundation Private Equity, Carpediem Capital Partners, Capri Global Holdings, several high-net-worth individuals, and promoter JP Shukla.
The startup will use the funds to expand its retail footprint across India. The company plans to scale its store count to 100 stores by 2029 from the current 65 outlets across 10 states, while targeting Rs 600 crore in revenue.
4point0 Health Ventures backs MedVital
MedVital, a startup focused on advanced skin repair and wound care, has raised nearly $982,456 (Rs 8.4 crore) in its pre-seed funding round led by Nihar Parikh’s 4point0 Health Ventures.
The round also saw participation from prominent healthcare and logistics entrepreneurs, including founders of Tata 1mg, NephroPlus, SafeExpress, Eye Q Hospital, Hexa Health, and AstroTalk.
MedVital plans to utilise the funds to strengthen its supply chain, broaden its distribution network to cover hospitals, clinics, and home-care environments, and expand its product portfolio in wound care and minimally invasive aesthetics.
